Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients

NCT06722599 · clinicaltrials.gov ↗
RECRUITING
Status
171
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Shu Wang